Reference
Memon R, et al. PCSK9 inhibitors-doubling hemoglobin A1c: A dilemma. Endocrine Practice 24 (Suppl. 1): 99, Apr 2018. Available from: URL: http://doi.org/10.4158/1530-891X-24.s1.1 [abstract] - USA
Rights and permissions
About this article
Cite this article
Alirocumab/evolocumab. Reactions Weekly 1712, 42 (2018). https://doi.org/10.1007/s40278-018-49331-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49331-6